10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q 

(Mark One)

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2022 

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

For the transition period from ____________ to ____________

Commission file number: 000-56332

Hawkeye Systems, Inc.

(Exact name of small business issuer as specified in its charter)

Nevada	83-0799093
(State or other jurisdiction  of incorporation or organization)	(IRS Employer Identification No.)

6605 Abercorn, Suite 204

Savannah, GA 31405

(Address of principal executive offices)

(912) 253-0375

(Registrants telephone number, including area code)

____________________________________________________________

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act

Title of Each Class	Trading  Symbol(s)	Name of each Exchange  on which registered
N/A	N/A	N/A

Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☐ Yes   ☒ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit). ☐ Yes   ☒ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Non-accelerated Filer	☒
Accelerated filer	☐	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Yes   ☐ No

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes   ☒ No

The number of shares outstanding of each of the issuer’s classes of common equity as of January 31, 2023, was 42,270,815 shares of common stock.

Contents

		Page
Part 1	FINANCIAL INFORMATION	2
Item 1	Financial Statements (unaudited)	2
	Condensed Consolidated Balance Sheets as of December 31, 2022 and June 30, 2022 (unaudited)	2
	Condensed Consolidated Statements of Operations for the three and six months ended December 31, 2022 and 2021(unaudited)	3
	Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three and six months ended December 31, 2022 and 2021 (unaudited)	4
	Condensed Consolidated Statements of Cash Flows for the three and six months ended December 31, 2022 and 2021 (unaudited)	5
	Notes to the Unaudited Condensed Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	11
Item 4.	Controls and Procedures	13
Part II.	OTHER INFORMATION	15
Item 1	Legal Proceedings	15
Item 1A	Risk Factors	15
Item 2	Unregistered Sales of Equity Securities and Use of Proceeds	15
Item 3	Defaults Upon Senior Securities	15
Item 4	Mine Safety Disclosures	15
Item 5	Other Information	15
Item 6	Exhibits	16
	SIGNATURES	17

2

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

	December 31,			June 30,
	2022			2022
ASSETS
Current assets:
Cash	$	32		$	325
Prepaid expenses		9,480			1,333
Total current assets		9,512			1,658
Total assets	$	9,512		$	1,658
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable and accrued liabilities	$	557,675		$	273,592
Convertible note payable - related party		500,000			500,000
Line of credit - related party		465,000			265,000
Common stock payable		20,000			-
Common stock payable - related party		10,000			624,344
Total current liabilities		1,525,260			1,662,936
Loan payable to Eagle - JV partner	$	442,251		$	442,251
Total liabilities		1,994,926			2,105,187
Commitments and contingencies (Notes 11)
Stockholders’ deficit:
Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding		-			-
Common stock, $0.0001 par value, 400,000,000 shares authorized; 42,270,815 and 25,604,148 shares issued and outstanding, respectively		4,227			2,560
Additional paid-in capital		9,373,923			8,776,087
Accumulated deficit		(11,363,564	)		(10,882,176	)
Total stockholders’ deficit		(1,985,414	)		(2,103,529	)
Total liabilities and stockholders’ deficit	$	9,512		$	1,658

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months Ended						Six Months Ended
	December 31,						December 31,
	2022			2021			2022			2021
Operating expenses:
General and administrative	$	21,212		$	91,154		$	48,966		$	114,043
Management compensation		111,250			225,440			222,551			396,739
Professional fees		86,865			12,864			107,291			39,134
Professional fees - related party		-			113,760			15,000			152,258
Marketing		-			2,695			-			2,695
Total operating expenses	$	219,327		$	445,913		$	393,808		$	704,869
Loss from operations	$	(219,327	)	$	(445,913	)	$	(393,808	)	$	(704,869	)
Other expense:
Interest expense	$	-		$	(43	)	$	-		$	(85	)
Interest expense - related party		(46,965	)		(40,886	)		(87,580	)		(63,803	)
Total other expense		(46,965	)		(40,929	)		(87,580	)		(63,888	)
Net loss	$	(266,292	)	$	(486,842	)	$	(481,388	)	$	(768,757	)
Net loss per common share - basic and diluted	$	(0.01	)	$	(0.02	)	$	(0.01	)	$	(0.04	)
Weighted average common shares outstanding - basic and diluted		42,270,815			23,265,176			39,825,815			20,604,565

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

(Unaudited)

For the Six Months ended December 31, 2022

					Additional
	Common Stock				Paid-in		Accumulated
	Shares		Amount		Capital		Deficit			Total
Balance, June 30, 2022		25,604,148	$	2,560	$	8,776,087	$	(10,882,176	)	$	(2,103,529	)
Common stock issued for common stock payable		16,666,667		1,667		592,677		-			594,344
Stock based compensation – options		-		-		5,159		-			5,159
Net loss								(215,096	)		(215,096	)
Balance, September 30, 2022		42,270,815	$	4,227	$	9,373,923	$	(11,097,272	)	$	(1,719,122	)
Net loss		-		-		-		(266,292	)		(266,292	)
Balance, December 31, 2022		42,270,815	$	4,227	$	9,737,923	$	(11,363,564	)	$	(1,985,414	)

For the Six Months ended December 31, 2021 (Restated)

					Additional
	Common Stock				Paid-in			Accumulated
	Shares		Amount		Capital			Deficit			Total
Balance, June 30, 2021		17,921,148	$	1,792	$	7,957,009		$	(9,713,661	)	$	(1,754,860	)
Common stock issued for settlement of debt		300,000		30		29,970			-			30,000
Stock based compensation – options		-		-		73,994			-			73,994
Net loss									(311,355	)		(311,355	)
Balance, September 30, 2021		18,221,148	$	1,822	$	8,060,973		$	(10,025,016	)	$	(1,962,221	)
Common shares issued for stock payable		1,108,000		111		276,889			-			277,000
Cumulative-effect adjustment from adoption of ASU 2020-06		-		-		(169,354	)		-			(19,627	)
Stock based compensation - options		-		-		284,727			-			284,727
Stock option cashless exercised		6,035,000		603		(603,000	)					-
Net loss		-		-		-			(486,842	)		(486,842	)
Balance, December 31, 2021		25,364,148	$	2,536		8,452,632		$	(10,362,131	)	$	(1,906,963	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Six Months Ended
	December 31,
	2022			2021
Cash flows from operating activities:
Net loss	$	(481,388	)	$	(768,757	)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock based compensation – options and warrant		5,159			358,721
Change in operating assets and liabilities:
Prepaid expense		(8,147	)		(22,833	)
Accounts payable and accrued liabilities		284,083			60,226
Net cash used in operating activities		(200,293	)		(372,643	)
Cash flows from financing activities:
Net proceeds from line of credit – related party		200,000			-
Net proceeds from convertible note - related party		-			105,000
Net cash provided by financing activities		200,000			105,000
Net change in cash		(293	)		(267,643	)
Cash beginning of period		325			282,131
Cash end of period	$	32		$	14,488
Supplemental cash flow information
Cash paid for interest	$	-		$	-
Cash paid for taxes	$	-		$	-
Non-cash investing and financing activities:
Common stock issued exchanged for common stock payable – related party	$	594,344		$	-
Common stock issued exchanged for common stock payable	$	-		$	277,000
Replacement of Inventory financing payable to convertible note	$	-		$	500,000
Common stock issued for settlement of debt	$	-		$	30,000
Stock option cashless exercised	$	-		$	603

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 

6

HAWKEYE SYSTEMS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2022

Note 1 - Summary of Significant Accounting Policies

Business Overview

Hawkeye Systems, Inc. (the “Company”), a Nevada corporation incorporated on May 15, 2018. We are a technology holding company, our previous focus was on pandemic management products and services. We are currently seeking other opportunities, while actively trying to liquidate mask inventory and wind-up existing deals. The Company looks to license and acquire technology that improves life and to work with partners to develop cutting edge, “smart” products for a variety of markets. From inception until the date of this filing our activities have primarily consisted of (i) the incorporation of our Company, (ii) the development of our business plan and the evaluation of strategic investment and business development strategies, (iii), recruiting and adding additional consultants and employees, and (iv) liquidating our stock of personal protective equipment (“PPE”) products through numerous sources.

Basis of presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited condensed consolidated financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended June 30, 2022, as filed with the SEC on December 14, 2022.

Use of estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, valuation of beneficial conversion feature on convertible notes and the valuation allowance on deferred tax assets.

Fair value measurements

When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis.

7

Revenue recognition

As of December 31, 2022, and 2021, the Company has no revenue.

Cost of sales

As of December 31, 2022, and 2021, the Company has no Cost of Sales.

Basic and diluted earnings per share

Basic earnings per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable with accrued interest. For the six months ended December 31, 2022 and 2021, potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share because they were anti-dilutive are as follows:

	December 31,		December 31,
	2022		2021
Warrants		2,393,996		2,493,996
Options		4,256,000		1,006,000
Convertible notes		56,792,686		32,250,000
Common stock payable		750,000		-
Total possible dilutive shares		64,192,682		35,749,996

Recent Accounting Pronouncements

Management has considered all recent accounting pronouncements issued and their potential effect on our financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s unaudited condensed consolidated financial statements.

In August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt-Debt with Conversion and Other Options” and ASC subtopic 815-40 “Hedging-Contracts in Entity’s Own Equity”. The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting; and, (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years.

We early adopted this standard effective July 1, 2021 using the modified retrospective approach transition method. Therefore, the condensed financial statements for the six months ended December 31, 2022 are presented under the new standard, while the comparative period presented is not adjusted and continues to be reported in accordance with the Company’s historical accounting policy.

8

Note 2 - Going Concern

The Company’s unaudited condensed consolidated financial statements are prepared using GAAP, applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. During the six months ended December 31, 2022, the Company had a net loss of $481,388. As of December 31, 2022, the Company had an accumulated deficit of $11,363,564.

The Company has not established sufficient revenue to cover its operating costs and will require additional capital to continue its operating plan. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations. These factors raise substantial doubt about its ability to continue as a going concern.

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plan to obtain such resources for the Company includes: sales of equity instruments; traditional financing, such as loans; and obtaining capital from management and significant stockholders sufficient to meet its minimum operating expenses. However, management cannot provide any assurance that the Company will be successful in accomplishing this plan.

There is no assurance that the Company will be able to obtain sufficient additional funds when needed or that such funds, if available, will be obtainable on terms satisfactory to the Company. In addition, profitability will ultimately depend upon the level of revenues received from business operations. However, there is no assurance that the Company will attain profitability. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Note 3 – Restatement of Financial Statements for the Quarter End December 31, 2021

On July 17, 2020, the Company entered into a membership agreement with Eagle Equities LLC (“Eagle”) and Ikon Supplies (“Ikon”) to form a Nevada Limited Liability Company, HIE, LLC (“HIE”) for the purpose of procuring, funding the purchase of and sale of PPE (the “Membership Agreement”). Subject to the provision of the Agreement, the interest of any net profits would be shared in a ratio of 33.3% among each member. Upon the occurrence of any loss in some or all of the HIE’s capital, all members would be responsible to contribute capital to repay the loan, and additional contribution, with each party being responsible for 33.3% of the loss.

Restatement Effect on Financial Statements

The Company did not receive any updates of the fiscal year 2021 financial statements from HIE until October, 2022. For the fiscal year ended June 30, 2021, HIE had a loan balance of $2,122,963 secured by Eagle, of which the Company has recognized 1/3 amounting to $707,654 as a guarantee of loan payable to Eagle - JV partner, the same amount as investment in HIE, as stipulated in the Membership Agreement. In addition, HIE incurred an operating loss of $1,385,962, which resulted in the Company recording 1/3 of its loss of $461,987 under other expenses on the statement of income to offset the investment in HIE as under equity method in accordance with FASB ASC 323.

As of June 30, 2021, the balance of investment in HIE was $245,667 and the balance of loan payable to Eagle - JV partner was $707,654. Since there were no operating activities or financial movement between July 1, 2021 to December 31, 2021, the investment in HIE and the loan payable to Eagle - JV partner are the same as of June 30, 2021.

9

Effects on the previously issued year 2021 balance sheet referencing the restatement of asset, liability and equity are as follows:

	Originally Reported			Restatement Adjustment			As Restated
Balance Sheet at December 31, 2021:
ASSETS
Current assets:
Cash	$	14,488		$	-		$	14,488
Prepaid expenses		25,833			-			25,833
Total current assets		40,321			-			40,321
Investment in HIE		-			245,667			245,667
Total assets	$	40,321		$	245,667		$	285,988
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable and accrued liabilities	$	163,314		$	-		$	163,314
Convertible note payable, net of discount - related party		1,105,000			-			1,105,000
Common stock payable - related party		200,000			-			200,000
Total current liabilities		1,468,314			-			1,468,314
Long-term liabilities:
Loan payable due to Eagle - JV partner		-			707,654			707,654
PPP loan		16,983			-			16,983
Total liabilities		1,485,297			707,654			2,192,951
Stockholders’ deficit:
Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding		-			-			-
Common stock, $0.0001 par value, 400,000,000 shares authorized; 25,604,148 shares issued and outstanding, respectively		2,536			-			2,536
Additional paid-in capital		8,452,632			-			8,452,632
Accumulated deficit		(9,900,144	)		(461,987	)		(10,362,131	)
Total stockholders’ equity deficit		(1,444,976	)		(461,987	)		(1,906,963	)
Total liabilities and stockholders’ deficit	$	40,321		$	(461,987	)	$	285,988

Since there were no operating activities between July 01, 2021 to December 31, 2021, the previously issued December 31, 2021 Statement of Operations has not changed.

10

Note 4 – Joint Venture Investment in HIE LLC

On July 17, 2020, the Company entered into a membership agreement with Eagle Equities LLC (“Eagle”) and Ikon Supplies (“Ikon”) to form a Nevada Limited Liability Company, HIE, LLC (“HIE”) for the purpose of procuring, funding the purchase of and sale of PPE (the “Membership Agreement”). Subject to the provision of the Agreement, the interest of any net profits would be shared 33.3% among each member. If there is a loss in some or all of the capital, all members of HIE shall be responsible to contribute capital to repay the loan, and additional contribution, with each party being responsible for 33.3% of the loss.

The joint venture investment in HIE LLC is accounted for by the Company using the equity method in accordance with FASB ASC 323. There were no operating activities in HIE during the quarter ended December 31, 2022.

As of December 31, 2022, and 2021, the balances of investment in HIE were $0, and $245,667, respectively.

Note 5 – Inventory Financing Payable – related party

On February 19, 2021, Steve Hall, an investor who holds approximately 72% of the Company’s common stock advanced $1 million to the Company. The purpose of the advance was to purchase inventory to satisfy customer orders. The advance would be repaid upon cash being received from the end customer. In addition to the principal amount of the advance, the related party will be entitled to 1/3 of the gross profit earned on the transaction. The terms of the agreement are non-interest bearing. The investor is 100% at risk as this is a non-recourse funding vehicle. 

In June 2021 the Company cancelled the contemplated purchase of inventory and returned $500,000 to Mr. Hall. Mr. Hall has agreed to allow the Company to retain the balance to fund future purchases and general operating expenses.

On October 1, 2021, the Company and Steve Hall entered into an agreement to replace the inventory financing payable with a convertible note. Further discussion on Note 6 – Convertible Notes Payable – related party, convertible promissory note 6.3.

The balances of the convertible note as of December 31, 2022, and 2021 are $0 and $500,000, respectively.

11

Note 6 – Convertible Notes Payable – related party

Convertible Promissory Note 6.1

On April 6, 2020, the Company and Steve Hall, entered into a convertible promissory note agreement for the principal amount of $250,000, accruing simple interest at a rate of 10% per annum if repaid within 90 days, and 20% per annum if repaid thereafter. The convertible note was due on April 6, 2021. At the option of the noteholder, the note would convert, at any time, starting six months from the date of issuance through to the one-year anniversary of the date of issuance at a conversion price of $0.25 per share.

The Company recorded a discount on the convertible note due to a beneficial conversion feature of $51,594, which was being amortized over the term of the note.

In consideration for the loan of $250,000, the Company also granted to Mr. Hall 100,000 stock options exercisable at $0.25 for a two-year term. The options vested upon issuance of the note. The fair value of the options was $13,297 and was recognized as debt discount as a part of beneficial conversion feature in the year ended 30, 2020.

The outstanding principal amount, and the related interest were converted into common stock on September 01, 2021.

Convertible Promissory Note 6.2

On December 15, 2020, the Company and Steve Hall, entered into a convertible promissory note agreement for the principal amount of $250,000, accruing simple interest at a rate of 10% per annum, if repaid within 90 days, and 20% per annum if repaid thereafter. The convertible note was due on December 15, 2021. At the option of the noteholder, the note would convert at any time beginning six months after the date of issuance and ending on the date, which is one year from the date of issuance, at a conversion price of $0.25 per share.

The Company recorded a discount on the convertible note due to a beneficial conversion feature of $117,760, which is being amortized over the term of the note.

In consideration for the loan of $250,000, the Company also granted to Mr. Hall 100,000 stock options exercisable at $0.25 for a two-year term. The options vested upon issuance of the note. The fair value of the options was $46,380 and was recognized as debt discount as a part of beneficial conversion feature in the year ended June 30, 2021.

The outstanding principal amount, and the related interest were converted into common stock on September 01, 2021.

Adoption of ASU 2020-06 for Convertible Promissory Note 6.1, and Convertible Promissory Note 6.2

In connection with the adoption of ASU 2020-06, the Company reclassified the aggregate amount of $169,354, previously allocated to the conversion feature of the Convertible Promissory Note 6.1, and Convertible Promissory Note 6.2 of $51,594, and $117,760 from additional paid-in capital to convertible notes on our balance sheet as of September 1, 2021, respectively. The reclassification was recorded to combine the two legacy units of account into a single instrument classified as a liability. The Company also recognized an aggregate cumulative effect adjustment of $120,287 to the Convertible Promissory Note 6.1, and Convertible Promissory Note 6.2 of $51,594, and $68,693 to accumulated deficit on our balance sheet as of September 1, 2021, respectively. The cumulative effect adjustment was primarily driven by the derecognition of interest expense related to the accretion of the Debt Discount as required under the legacy accounting guidance. Under ASU 2020-06, we would no longer incur non-cash interest expense related to the accretion of the debt discount associated with the embedded conversion option.

Conversion of Convertible Promissory Note 6.1 and Convertible Promissory Note 6.2

On September 1, 2021, the Company had converted the convertible promissory note 6.1 and convertible promissory note 6.2 in the aggregate total of $500,000 and the related accrued interest of $94,344 into 16,666,667 shares of common stock with conversion value of $0.035661 per share. The entire amount of $594,344 has been converted into Common Stock on July 28, 2022. On November 2, 2021, the Company issued 160,000 shares of common stock for cashless exercise of the 200,000 stock options issued to Mr. Hall.

12

Exercise of the stock options on Convertible Promissory Note 6.1 and Convertible Promissory Note 6.2

On November 2, 2021, the Company issued 160,000 shares of common stock for the cashless exercise of the 200,000 stock options, mentioned in convertible promissory note 6.1 and convertible promissory note 6.2.

Convertible Promissory Note 6.3

On October 1, 2021, the inventory financing payable of $500,000 with Steve Hall as mentioned on Note 5 – Inventory Financing Payable – related party, has been exchanged for a convertible promissory note with annual simple interest rate of 12% for the first 90 days and annual simple interest rate of 20% thereafter, with a due date on September 30, 2022. At the option of holder, this note is convertible, at any time, into shares of common stock at a conversion price of $0.02 per share.

The note’s maturity date was extended to September 30, 2023.

As of December 31, 2022, the accrued interest under the note was $115,342, and the principal balance was $500,000.

Note 7 – Line of Credit – related party

On October 1, 2021, Steve Hall agreed to provide a line of credit of up to $1,000,000 to the Company with simple interest at a rate of 12% for the first 90 days, and simple interest at a rate of 20% per annum thereafter. The principal and interest payable shall be added to the principal amount of the agreement and payable pursuant to the same terms. The line of credit shall expire on October 1, 2022 unless renewed and/or extended by lender and borrower. Subsequently, the line of credit has been renewed and extended with same terms and an expiration date of October 1, 2023.

During the six months ended December 31, 2022, and 2021, in multiple transactions dates, the Company has withdrawn a total of $200,000, and 105,000, and has accrued interest of $11,280, and $962, respectively.

As of December 31, 2022, and 2021, the outstanding principal totaled $465,000, and 105,000 with accrued interest of $52,184, and $962, respectively.

Note 8 – Common stock payable

On May 23, 2022, the board of directors granted Richard Cutler, former director who had resigned in August 2022, 500,000 shares of restricted common stock valued at $20,000, with an exercise price of $0.04 per share. The shares were granted as consideration for services granted. All shares are restricted until an acquisition or reverse takeover of the Company.

As of December 31, 2022 and 2021, the Company reported common stock payable of $20,000 and $0, which represents 500,000, and 0 shares of common stock to be issued, respectively.

Note 9 – Common stock payable – related party

On May 23, 2022, the board of directors granted Chris Mulgrew, Chief Financial Officer, 250,000 shares of restricted common stock, valued at $10,000 with an exercise price of $0.04 per share. The shares were granted as consideration for services granted. All shares are restricted until an acquisition or reverse takeover of the Company.

As of December 31, 2022 and 2021, the Company reported common stock payable-related party of $10,000 and $20,000, which represents 250,000, and 1,108,000 shares of common stock to be issued, respectively.

13

Note 10 - Stockholders’ Equity

Common Stock

During the six months ended December 31, 2022, the Company had the following common stock transactions:

· 16,666,667 shares issued valued at $594,344 for settlement of two convertible notes to Steve Hall in aggregate amount of $500,000 and accrued interest of $94,344.  

Stock Purchase Warrants

Transactions in stock purchase warrants for the six months ended December 31, 2022 are as follows:

	Number of			Weighted Average
	Warrants			Exercise Price
Balance at June 30, 2021		2,493,996		$	1.00
Granted		-			-
Exercised – shares issued		-			-
Expired		-			-
Balance at September 30, 2022		2,493,996		$	1.00
Expired		(100,000	)		0.20
Balance at December 31, 2022		2,393,996		$	1.03

The composition of the Company’s warrants outstanding at December 31, 2022 are as follows:

Exercise Price		Number of Warrants		Weighted Average Remaining Life (in years)
$	0.30		349,998		1.33
$	0.50		666,666		1.33
$	1.00		708,666		1.33
$	2.00		668,666		1.33
			2,393,996		1.33

At December 31, 2022, the intrinsic value of the 2,393,996 outstanding warrant was $0.

14

Stock Options

Transactions in stock options for the six months ended December 31, 2022 are as follows:

					Weighted average
	Number of		Weighted average		remaining life
	options		exercise price		(in years)
Outstanding, June 30, 2022		4,256,000		0.14		4.41
Granted		-		-		-
Cancelled		-		-		-
Exercised		-		-		-
Outstanding, December 31, 2022		4,256,000		0.14		3.90
Exercisable, December 31, 2022		4,256,000	$	0.14		3.90

During the six months ended December 31, 2022, $5,159 was expensed to un-related parties, and $0 remains unamortized.

At December 31, 2022, the intrinsic value of the 4,256,000 outstanding options was $0.

Note 11 - Commitments and Contingencies 

On July 17, 2020, the Company entered into a Membership Agreement (See “Note 4 - Joint Venture Investment in HIE LLC ”). Under the terms and conditions of the Membership Agreement, in the event of a loss of capital of HIE, the Company shall contribute to repay 33.3% of the Origination Loan and Additional Contribution and of any losses of HIE.

In addition, the Company is obliged to repay 1/3 of the loan contributed by Eagle or 1/3 of the capital paid by Eagle according to the membership agreement. As of December 31, 2022, and 2021, the balances of loan payable to Eagle - JV partner totaled $442,251, and $707,654, respectively.

HIE had no operating activities for the six months ended December 31, 2022. 

Note 12 - Subsequent Events

Management has evaluated subsequent events through the date these financial statements were available to be issued. Based on our evaluation no material events have occurred that require disclosure.

15

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

The following discussion relates to the historical operations and financial statements of Hawkeye Systems, Inc. for the six months ended December 31, 2022.

Forward-Looking Statements

The following Management’s Discussion and Analysis should be read in conjunction with our financial statements and the related notes thereto included elsewhere in this quarterly report. The Management’s Discussion and Analysis contains forward-looking statements that involve risks and uncertainties, such as statements of our plans, objectives, expectations and intentions. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect,” and the like, and/or future-tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements in this Annual Report. Our actual results and the timing of events could differ materially from those anticipated in these forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, without limitation, those specifically addressed under the heading “Risks Factors” in our various filings with the Securities and Exchange Commission. We do not undertake any obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this quarterly report.

Financial Condition and Results of Operations

We have incurred recurring losses to date. Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operation.

We expect we will require additional capital to meet our long-term operating requirements. We expect to raise additional capital through, among other things, the sale of equity or debt securities.

Results of Operations

Six months ended December 31, 2022 compared to six months ended December 31, 2021

We had no operating revenues, and cost of sales, for the six months ended December 31, 2022 and 2021, respectively.

Total operating expenses in the six months ended December 31, 2022 were $393,808 compared to $704,869 for the same period in 2021. The decrease in operating expenses is primarily a result of decreased professional fees - related party, management compensation, and general and administrative expenses. The Company’s net loss was $481,388 for the six months ended December 31, 2022 compared to $768,757 for the six months ended December 31, 2021. The net loss for this period is primarily a result of operating expenses, and interest expense.

16

Liquidity and Capital Resources

Our cash balance at December 31, 2022 was $32 compared to $14,488 at December 31, 2021. We do not believe these cash reserves are sufficient to cover our expenses for our operations for fiscal year ending June 30, 2023. We will require additional funding for our ongoing operations.

In addition, we intend to raise funds through the sale of equity and the exercise of warrants issued in private placements. Although to date we have had some warrant exercises for cash, there can be no assurance that we will be able to raise money through offerings or through the exercise of warrants. If we cannot raise any additional financing prior to the expiration of the first quarter of 2023, we believe we will be able to obtain loans from management in the future, if necessary, but have no agreement in writing.

We are a smaller reporting company and have accumulated losses to date. Under a limited operations scenario to maintain our corporate existence, we believe we will require additional funds over the next 12 months to complete our regulatory reporting and filings. However, we will require maximum participation through private placements, warrant exercises or alternative financings to implement our business plan.

There are no assurances that we will be able to obtain further funds required for our continued operations. Even if additional financing is available, it may not be available on terms we find favorable. Failure to secure the needed additional financing will have an adverse effect on our ability to remain in business.

Plan of Operation and Funding

We expect that working capital requirements will continue to be funded through equity offerings, warrant exercises, and related party advances in the near future. We have no guarantees or firm commitments that the related party advances will continue in the near future.

Existing working capital, further advances, together with anticipated capital raises are expected to be adequate to fund our operations over the next twelve months, but there is no guarantee that we will be successful in raising enough capital, or that we will receive the cash flow required to fund our operations. We have no lines of credit with banking institutions or other bank financing arrangements, we do have a line a credit form a related party (see Note 7 to the Financial Statements). Generally, we have financed operations to date through proceeds from the sale of our common stock, warrant exercises and convertible loans.

Management anticipates additional increases in operating expenses relating to: (i) developmental expenses; and (ii) legal and accounting fees, required to complete our filings with the SEC. We intend to finance these expenses with issuances of securities and through the exercise of outstanding warrants.

Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders. Further, such securities might have rights, preferences, or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to continue our operations.

Material Commitments

As of the date of this quarterly report, we do not have any material commitments.

Purchase of Significant Equipment

We do not intend to purchase any significant equipment during the next twelve months.

Off-Balance Sheet Arrangements

As of the date of this quarterly report, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

17

Going Concern

As reflected in the accompanying financial statements, the Company had an accumulated deficit of approximately $11,336,564 at December 31, 2022 and net loss from operations of $393,808.

The Company does not yet have a history of financial stability. Historically, the principal source of liquidity has been the issuance of equity securities and related party advances. In addition, the Company is in the development stage and has accumulated losses since inception. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

The ability of the Company to continue operations is dependent on the success of Management’s plans and raising of capital through the issuance of equity securities, until such time that funds provided by operations are sufficient to fund working capital requirements.

The Company will require additional funding to finance its operations as well as to identify, negotiate and materialize a business combination with a target business. The Company believes its current available cash may be insufficient to meet its cash needs for the near future. There can be no assurance that financing will be available in amounts or terms acceptable to the Company, if at all.

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

Critical Accounting Policies and Estimates

For a discussion of our accounting policies and related items, please see the Notes to the Financial Statements, included in Item 2.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES

Management’s Annual Report on Internal Control over Financial Reporting. 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes of accounting principles generally accepted in the United States. In our review, we sought to find potential for material weaknesses in our financial controls, which is defined as a deficiency, or combination of deficiencies, in our accounting such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.

Because of its inherent limitations, which include a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures, internal control over financial reporting may not prevent or detect misstatement, whether unintentional errors or fraud. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives.

Our management, consisting of Corby Marshall as Chief Executive Officer and Christopher Mulgrew as Chief Financial Officer, reviewed and evaluated the effectiveness of the Company’s internal control over disclosure controls and procedures (as such term is defined in Rules 13a-15(3) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)) and financial reporting as of December 31, 2022. In making this assessment, our management used the criteria described in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), as well as the guidance provided in SEC Release 33-8809. In such evaluation, Mr. Marshall and Mr. Mulgrew assessed daily interaction, self-assessment and other on going monitoring activities as evidence in the evaluation. Furthermore we sought to identify financial reporting risks, identify controls that adequately address financial reporting risks, considered entity level controls, reviewed the role of technology in our controls and reviewed the evidence available to support the assessment.

18

Based on this evaluation, our management concluded that, as of December 31, 2022, our disclosure controls and our internal controls over financial reporting were not effective in recording, processing, summarizing and reporting on a timely basis information required to be disclosed in the reports that we file or submit under the Exchange Act and were not effective in assuring that information required to be disclosed in the reports we file or submit under the Exchange Act due to material weaknesses including (i) the Company having only two officers handling all financial transactions, (ii) lack of appropriate operational controls and consistency in providing our accounting personnel with financial information, (iii) incomplete financial statements on a daily basis and resulting errors in our underlying accounting system, (iv) lack of proper documentation of our assessment and evaluation, and (v) our determination that internal controls were ineffective due to the limited segregation of duties because of the limited management structure.

In response to that assessment we have made a determination that all accounting and financial reporting services should be outsourced to a qualified consulting firm, and we immediately engaged a new financial services provider. We subsequently replaced that provider with an internal accounting contractor.

We have also made the determination that we need to dedicate more of the Company’s current and future financial resources to this function and engaged a permanent Chief Financial Officer.

This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to rules of the SEC that permits us to provide only management’s report in this annual report.

Changes in Internal Control over Financial Reporting. 

Other than engaging a new financial services firm to provide financial statements, there were no changes in our internal control over financial reporting that occurred during the quarter ended December 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

19

PART II - OTHER INFORMATION

Item 1 - Legal Proceedings

On September 19, 2019, the Company entered into a Stock Purchase Agreement with Radiant Images, Inc., a California corporation (“Radiant”), as well as Radiant’s shareholder Gianna Wolfe (“Wolfe”) and key employee, Michael Mansouri (“Mansouri”), pursuant to which the Company would acquire 100% of the shares of common stock (the “Shares”) of Radiant from Wolfe, resulting in the acquisition of Radiant. In April 2020, the Company received notice from Radiant of their intent to terminate the Company’s acquisition agreement. Although the Company believes that the termination is not legally valid, the Company ceased further discussions with respect to the acquisition and engaged counsel to pursue litigation for repayment of amounts due by Radiant. The Company’s investment in Radiant was structured as a revolving note. Pursuant to the terms of the revolving note, Radiant is required to repay the money already invested to Hawkeye with interest. The note receivable was issued on April 26, 2019, is due upon demand of the Company at any time commencing April 26, 2020. The interest rate on the note is 12% and accrues daily on the outstanding balance. At June 30, 2020 interest income of $154,042 had been accrued on the note. Under accounting treatment, this note, and interest were impaired on our balance sheet while we resolved this dispute. We had filed a complaint against Radiant and its principals and intended to vigorously pursue this matter and litigation. The dispute was amicably resolved by the parties by means of a Settlement Agreement and Release of All Claims dated November 17, 2021, whereby the Company as “plaintiff” and “cross-defendant” released, and was in turned released, by Radiant, Gianna Wolfe and Michael Mansouri from any and all claims in connection with the stock purchase agreement and revolving note. No payment was due to or made by the Company in connection with the settlement and release of this action.

On November 13, 2019, 5W Public Relations LLC (“5W”) filed a complaint against Hawkeye Systems, Inc. relating to payments allegedly due under a contract for public relations services. Hawkeye vigorously disputed the allegations in the complaint as 5W Public Relations provided virtually no services to Hawkeye during the term of this arrangement but was paid a substantial amount of funds. Hawkeye engaged counsel to provide counterclaims for failure of consideration, fraud in the inducement, general fraud, and other causes of action. This proceeding was resolved by a Stipulation of Settlement dated May 19, 2022, filed with the Supreme Court of the State of New York. The Company settled all of 5W’s claims for the sum of $30,000. 

Other than the foregoing, we are not aware of any legal proceedings contemplated by any governmental authority or any other party involving us or our properties. As of the date of this report, no director, officer, or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. We are not aware of any other legal proceedings pending or that have been threatened against us or our properties.

From time to time the Company may be named in claims arising in the ordinary course of business. Currently, no legal proceedings or claims, other than those disclosed above, are pending against or involve the Company that, in the opinion of management, could reasonably be expected to have a material adverse effect on its business and financial condition.

Item 1A - Risk Factors

Not required for Smaller Reporting Companies.

Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds

No disclosure required.

Item 3 - Defaults Upon Senior Securities

No disclosure required.

Item 4 - Mine Safety Disclosure

No disclosure required.

Item 5 - Other Information

No disclosure required.

20

Item 6 - Exhibits

Exhibits:

Number	Description
31.1*	Certification of Chief Executive Officer, pursuant to SEC Rules 13a-14(a) and 15d-14(a), adopted pursuant Section 302 of the Sarbanes Oxley Act of 2002
31.2*	Certification of Chief Financial Officer, pursuant to SEC Rules 13a-14(a) and 15d-14(a), adopted pursuant Section 302 of the Sarbanes Oxley Act of 2002
32.1*	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**	Certification of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101*	Inline XBRL Document Set for the condensed consolidated financial statements and accompanying notes in Part I, Item 1, “Financial Statements” of this Quarterly Report on Form 10-Q.
104*	Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.

___________ 

* Filed herewith.

** Furnished herewith.

21

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Hawkeye Systems, Inc.
Date: January 31, 2023	By:	/s/ Corby Marshall
		Corby Marshall, Chief Executive Officer
		Principal Executive Officer
Date: January 31, 2023	By:	/s/ Christopher Mulgrew
		Christopher Mulgrew, Chief Financial Officer
		Principal Financial Officer

22

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, Corby Marshall, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Hawkeye Systems, Inc. (the “Registrant”);
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;
4.	I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;
b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial; and
b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: January 31, 2023	/s/ Corby Marshall
	Corby Marshall
	Chief Executive Officer
	(Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, Christopher Mulgrew, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Hawkeye Systems, Inc. (the “Registrant”);
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;
4.	I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;
b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial; and
b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: January 31, 2023	/s/ Christopher Mulgrew
	Christopher Mulgrew
	Chief Financial Officer
	(Principal Financial Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Hawkeye Systems, Inc. (the “Company”) on Form 10-Q for the period ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Corby Marshall, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company

Date: January 31, 2023	/s/ Corby Marshall
	Corby Marshall
	Chief Executive Officer
	(Principal Executive Officer)

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Hawkeye Systems, Inc. (the “Company”) on Form 10-Q for the period ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Christopher Mulgrew, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company

Date: January 31, 2023	/s/ Christopher Mulgrew
	Christopher Mulgrew
	Chief Financial Officer
	(Principal Financial Officer)

XML

Cover - shares	6 Months Ended
	Dec. 31, 2022	Jan. 31, 2023
Cover [Abstract]
Entity Registrant Name	Hawkeye Systems, Inc.
Entity Central Index Key	0001750777
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	No
Document Period End Date	Dec. 31, 2022
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2023
Entity Common Stock Shares Outstanding		42,270,815
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-56332
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	83-0799093
Entity Address Address Line 1	6605 Abercorn
Entity Address Address Line 2	Suite 204
Entity Address City Or Town	Savannah
Entity Address State Or Province	GA
Entity Address Postal Zip Code	31405
City Area Code	912
Local Phone Number	253-0375
Entity Interactive Data Current	No

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2022	Jun. 30, 2022
Current assets:
Cash	$ 32	$ 325
Prepaid expenses	9,480	1,333
Total current assets	9,512	1,658
Total assets	9,512	1,658
Current liabilities:
Accounts payable and accrued liabilities	557,675	273,592
Convertible note payable - related party	500,000	500,000
Line of credit - related party	465,000	265,000
Common stock payable	20,000	0
Common stock payable - related party	10,000	624,344
Total current liabilities	1,525,260	1,662,936
Loan payable to Eagle - JV partner	442,251	442,251
Total liabilities	1,994,926	2,105,187
Stockholders' deficit:
Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding	0	0
Common stock, $0.0001 par value, 400,000,000 shares authorized; 42,270,815 and 25,604,148 shares issued and outstanding, respectively	4,227	2,560
Additional paid-in capital	9,373,923	8,776,087
Accumulated deficit	(11,363,564)	(10,882,176)
Total stockholders' deficit	(1,985,414)	(2,103,529)
Total liabilities and stockholders' deficit	$ 9,512	$ 1,658

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2022	Jun. 30, 2022
CONDENSED CONSOLIDATED BALANCE SHEETS
Preferred stock, shares par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, shares par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	42,270,815	25,604,148
Common stock, shares outstanding	42,270,815	25,604,148

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Operating expenses:
General and administrative	$ 21,212	$ 91,154	$ 48,966	$ 114,043
Management compensation	111,250	225,440	222,551	396,739
Professional fees	86,865	12,864	107,291	39,134
Professional fees - related party	0	113,760	15,000	152,258
Marketing	0	2,695	0	2,695
Total operating expenses	219,327	445,913	393,808	704,869
Loss from operations	(219,327)	(445,913)	(393,808)	(704,869)
Other expense:
Interest expense	0	(43)	0	(85)
Interest expense - related party	(46,965)	(40,886)	(87,580)	(63,803)
Total other expense	(46,965)	(40,929)	(87,580)	(63,888)
Net loss	$ (266,292)	$ (486,842)	$ (481,388)	$ (768,757)
Net loss per common share - basic and diluted	$ (0.01)	$ (0.02)	$ (0.01)	$ (0.04)
Weighted average common shares outstanding - basic and diluted	42,270,815	23,265,176	39,825,815	20,604,565

XML

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY (DEFICIT) (Unaudited) - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Balance, shares at Jun. 30, 2021		17,921,148
Balance, amount at Jun. 30, 2021	$ (1,754,860)	$ 1,792	$ 7,957,009	$ (9,713,661)
Common stock issued for settlement of debt, shares		300,000
Common stock issued for settlement of debt, amount	30,000	$ 30	29,970	0
Stock based compensation - options	73,994	$ 0	73,994	0
Net loss	(311,355)			(311,355)
Balance, shares at Sep. 30, 2021		18,221,148
Balance, amount at Sep. 30, 2021	(1,962,221)	$ 1,822	8,060,973	(10,025,016)
Balance, shares at Jun. 30, 2021		17,921,148
Balance, amount at Jun. 30, 2021	(1,754,860)	$ 1,792	7,957,009	(9,713,661)
Net loss	(768,757)
Balance, shares at Dec. 31, 2021		25,364,148
Balance, amount at Dec. 31, 2021	(1,906,963)	$ 2,536	8,452,632	(10,362,131)
Balance, shares at Sep. 30, 2021		18,221,148
Balance, amount at Sep. 30, 2021	(1,962,221)	$ 1,822	8,060,973	(10,025,016)
Stock based compensation - options	284,727	0	284,727	0
Net loss	(486,842)	$ 0	0	(486,842)
Common shares issued for stock payable, shares		1,108,000
Common shares issued for stock payable, amount	277,000	$ 111	276,889	0
Cumulative-effect adjustment from adoption of ASU 2020-06	(19,627)	$ 0	(169,354)	0
Stock option cashless exercised, shares		6,035,000
Stock option cashless exercised, amount	0	$ 603	(603,000)
Balance, shares at Dec. 31, 2021		25,364,148
Balance, amount at Dec. 31, 2021	(1,906,963)	$ 2,536	8,452,632	(10,362,131)
Balance, shares at Jun. 30, 2022		25,604,148
Balance, amount at Jun. 30, 2022	(2,103,529)	$ 2,560	8,776,087	(10,882,176)
Stock based compensation - options	5,159	$ 0	5,159	0
Net loss	(215,096)			(215,096)
Common stock issued for common stock payable, shares		16,666,667
Common stock issued for common stock payable, amount	594,344	$ 1,667	592,677	0
Balance, shares at Sep. 30, 2022		42,270,815
Balance, amount at Sep. 30, 2022	(1,719,122)	$ 4,227	9,373,923	(11,097,272)
Balance, shares at Jun. 30, 2022		25,604,148
Balance, amount at Jun. 30, 2022	(2,103,529)	$ 2,560	8,776,087	(10,882,176)
Net loss	(481,388)
Balance, shares at Dec. 31, 2022		42,270,815
Balance, amount at Dec. 31, 2022	(1,985,414)	$ 4,227	9,737,923	(11,363,564)
Balance, shares at Sep. 30, 2022		42,270,815
Balance, amount at Sep. 30, 2022	(1,719,122)	$ 4,227	9,373,923	(11,097,272)
Net loss	(266,292)	$ 0	0	(266,292)
Balance, shares at Dec. 31, 2022		42,270,815
Balance, amount at Dec. 31, 2022	$ (1,985,414)	$ 4,227	$ 9,737,923	$ (11,363,564)

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ (481,388)	$ (768,757)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock based compensation - options and warrant	5,159	358,721
Change in operating assets and liabilities:
Prepaid expense	(8,147)	(22,833)
Accounts payable and accrued liabilities	284,083	60,226
Net cash used in operating activities	(200,293)	(372,643)
Cash flows from financing activities:
Net proceeds from line of credit - related party	200,000	0
Net proceeds from convertible note - related party	0	105,000
Net cash provided by financing activities	200,000	105,000
Net change in cash	(293)	(267,643)
Cash beginning of period	325	282,131
Cash end of period	32	14,488
Supplemental cash flow information
Cash paid for interest	0	0
Cash paid for taxes	0	0
Non-cash investing and financing activities:
Common stock issued exchanged for common stock payable - related party	594,344	0
Common stock issued exchanged for common stock payable	0	277,000
Replacement of Inventory financing payable to convertible note	0	500,000
Common stock issued for settlement of debt	$ 0	30,000
Stock option cashless exercised		$ 603

XML

Summary of Significant Accounting Policies

6 Months Ended

Dec. 31, 2022

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Note 1 - Summary of Significant Accounting Policies

Business Overview

Hawkeye Systems, Inc. (the “Company”), a Nevada corporation incorporated on May 15, 2018. We are a technology holding company, our previous focus was on pandemic management products and services. We are currently seeking other opportunities, while actively trying to liquidate mask inventory and wind-up existing deals. The Company looks to license and acquire technology that improves life and to work with partners to develop cutting edge, “smart” products for a variety of markets. From inception until the date of this filing our activities have primarily consisted of (i) the incorporation of our Company, (ii) the development of our business plan and the evaluation of strategic investment and business development strategies, (iii), recruiting and adding additional consultants and employees, and (iv) liquidating our stock of personal protective equipment (“PPE”) products through numerous sources.

Basis of presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited condensed consolidated financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended June 30, 2022, as filed with the SEC on December 14, 2022.

Use of estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, valuation of beneficial conversion feature on convertible notes and the valuation allowance on deferred tax assets.

Fair value measurements

When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis.

Revenue recognition

As of December 31, 2022, and 2021, the Company has no revenue.

Cost of sales

As of December 31, 2022, and 2021, the Company has no Cost of Sales.

Basic and diluted earnings per share

Basic earnings per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable with accrued interest. For the six months ended December 31, 2022 and 2021, potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share because they were anti-dilutive are as follows:

	December 31,		December 31,
	2022		2021
Warrants		2,393,996		2,493,996
Options		4,256,000		1,006,000
Convertible notes		56,792,686		32,250,000
Common stock payable		750,000		-
Total possible dilutive shares		64,192,682		35,749,996

Recent Accounting Pronouncements

Management has considered all recent accounting pronouncements issued and their potential effect on our financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s unaudited condensed consolidated financial statements.

In August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt-Debt with Conversion and Other Options” and ASC subtopic 815-40 “Hedging-Contracts in Entity’s Own Equity”. The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting; and, (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years.

We early adopted this standard effective July 1, 2021 using the modified retrospective approach transition method. Therefore, the condensed financial statements for the six months ended December 31, 2022 are presented under the new standard, while the comparative period presented is not adjusted and continues to be reported in accordance with the Company’s historical accounting policy.

XML

Going Concern

6 Months Ended

Dec. 31, 2022

Going Concern

Going Concern

Note 2 - Going Concern

The Company’s unaudited condensed consolidated financial statements are prepared using GAAP, applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. During the six months ended December 31, 2022, the Company had a net loss of $481,388. As of December 31, 2022, the Company had an accumulated deficit of $11,363,564.

The Company has not established sufficient revenue to cover its operating costs and will require additional capital to continue its operating plan. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations. These factors raise substantial doubt about its ability to continue as a going concern.

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plan to obtain such resources for the Company includes: sales of equity instruments; traditional financing, such as loans; and obtaining capital from management and significant stockholders sufficient to meet its minimum operating expenses. However, management cannot provide any assurance that the Company will be successful in accomplishing this plan.

There is no assurance that the Company will be able to obtain sufficient additional funds when needed or that such funds, if available, will be obtainable on terms satisfactory to the Company. In addition, profitability will ultimately depend upon the level of revenues received from business operations. However, there is no assurance that the Company will attain profitability. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

XML

Restatement of Financial Statements for the Quarter End December 31, 2021

6 Months Ended

Dec. 31, 2022

Restatement of Financial Statements for the Quarter End December 31, 2021

Restatement of Financial Statements for the Quarter End December 31, 2021

Note 3 – Restatement of Financial Statements for the Quarter End December 31, 2021

On July 17, 2020, the Company entered into a membership agreement with Eagle Equities LLC (“Eagle”) and Ikon Supplies (“Ikon”) to form a Nevada Limited Liability Company, HIE, LLC (“HIE”) for the purpose of procuring, funding the purchase of and sale of PPE (the “Membership Agreement”). Subject to the provision of the Agreement, the interest of any net profits would be shared in a ratio of 33.3% among each member. Upon the occurrence of any loss in some or all of the HIE’s capital, all members would be responsible to contribute capital to repay the loan, and additional contribution, with each party being responsible for 33.3% of the loss.

Restatement Effect on Financial Statements

The Company did not receive any updates of the fiscal year 2021 financial statements from HIE until October, 2022. For the fiscal year ended June 30, 2021, HIE had a loan balance of $2,122,963 secured by Eagle, of which the Company has recognized 1/3 amounting to $707,654 as a guarantee of loan payable to Eagle - JV partner, the same amount as investment in HIE, as stipulated in the Membership Agreement. In addition, HIE incurred an operating loss of $1,385,962, which resulted in the Company recording 1/3 of its loss of $461,987 under other expenses on the statement of income to offset the investment in HIE as under equity method in accordance with FASB ASC 323.

As of June 30, 2021, the balance of investment in HIE was $245,667 and the balance of loan payable to Eagle - JV partner was $707,654. Since there were no operating activities or financial movement between July 1, 2021 to December 31, 2021, the investment in HIE and the loan payable to Eagle - JV partner are the same as of June 30, 2021.

Effects on the previously issued year 2021 balance sheet referencing the restatement of asset, liability and equity are as follows:

	Originally Reported			Restatement Adjustment			As Restated
Balance Sheet at December 31, 2021:
ASSETS
Current assets:
Cash	$	14,488		$	-		$	14,488
Prepaid expenses		25,833			-			25,833
Total current assets		40,321			-			40,321
Investment in HIE		-			245,667			245,667
Total assets	$	40,321		$	245,667		$	285,988
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable and accrued liabilities	$	163,314		$	-		$	163,314
Convertible note payable, net of discount - related party		1,105,000			-			1,105,000
Common stock payable - related party		200,000			-			200,000
Total current liabilities		1,468,314			-			1,468,314
Long-term liabilities:
Loan payable due to Eagle - JV partner		-			707,654			707,654
PPP loan		16,983			-			16,983
Total liabilities		1,485,297			707,654			2,192,951
Stockholders’ deficit:
Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding		-			-			-
Common stock, $0.0001 par value, 400,000,000 shares authorized; 25,604,148 shares issued and outstanding, respectively		2,536			-			2,536
Additional paid-in capital		8,452,632			-			8,452,632
Accumulated deficit		(9,900,144	)		(461,987	)		(10,362,131	)
Total stockholders’ equity deficit		(1,444,976	)		(461,987	)		(1,906,963	)
Total liabilities and stockholders’ deficit	$	40,321		$	(461,987	)	$	285,988

Since there were no operating activities between July 01, 2021 to December 31, 2021, the previously issued December 31, 2021 Statement of Operations has not changed.

XML

Joint Venture Investment in HIE LLC

6 Months Ended

Dec. 31, 2022

Joint Venture Investment in HIE LLC

Joint Venture Investment in HIE LLC

Note 4 – Joint Venture Investment in HIE LLC

On July 17, 2020, the Company entered into a membership agreement with Eagle Equities LLC (“Eagle”) and Ikon Supplies (“Ikon”) to form a Nevada Limited Liability Company, HIE, LLC (“HIE”) for the purpose of procuring, funding the purchase of and sale of PPE (the “Membership Agreement”). Subject to the provision of the Agreement, the interest of any net profits would be shared 33.3% among each member. If there is a loss in some or all of the capital, all members of HIE shall be responsible to contribute capital to repay the loan, and additional contribution, with each party being responsible for 33.3% of the loss.

The joint venture investment in HIE LLC is accounted for by the Company using the equity method in accordance with FASB ASC 323. There were no operating activities in HIE during the quarter ended December 31, 2022.

As of December 31, 2022, and 2021, the balances of investment in HIE were $0, and $245,667, respectively.

XML

Inventory Financing Payable related party

6 Months Ended

Dec. 31, 2022

Inventory Financing Payable related party

Inventory Financing Payable - related party

Note 5 – Inventory Financing Payable – related party

On February 19, 2021, Steve Hall, an investor who holds approximately 72% of the Company’s common stock advanced $1 million to the Company. The purpose of the advance was to purchase inventory to satisfy customer orders. The advance would be repaid upon cash being received from the end customer. In addition to the principal amount of the advance, the related party will be entitled to 1/3 of the gross profit earned on the transaction. The terms of the agreement are non-interest bearing. The investor is 100% at risk as this is a non-recourse funding vehicle. 

In June 2021 the Company cancelled the contemplated purchase of inventory and returned $500,000 to Mr. Hall. Mr. Hall has agreed to allow the Company to retain the balance to fund future purchases and general operating expenses.

On October 1, 2021, the Company and Steve Hall entered into an agreement to replace the inventory financing payable with a convertible note. Further discussion on Note 6 – Convertible Notes Payable – related party, convertible promissory note 6.3.

The balances of the convertible note as of December 31, 2022, and 2021 are $0 and $500,000, respectively.

XML

Convertible Notes Payable related party

6 Months Ended

Dec. 31, 2022

Convertible Notes Payable related party

Convertible Notes Payable - related party

Note 6 – Convertible Notes Payable – related party

Convertible Promissory Note 6.1

On April 6, 2020, the Company and Steve Hall, entered into a convertible promissory note agreement for the principal amount of $250,000, accruing simple interest at a rate of 10% per annum if repaid within 90 days, and 20% per annum if repaid thereafter. The convertible note was due on April 6, 2021. At the option of the noteholder, the note would convert, at any time, starting six months from the date of issuance through to the one-year anniversary of the date of issuance at a conversion price of $0.25 per share.

The Company recorded a discount on the convertible note due to a beneficial conversion feature of $51,594, which was being amortized over the term of the note.

In consideration for the loan of $250,000, the Company also granted to Mr. Hall 100,000 stock options exercisable at $0.25 for a two-year term. The options vested upon issuance of the note. The fair value of the options was $13,297 and was recognized as debt discount as a part of beneficial conversion feature in the year ended 30, 2020.

The outstanding principal amount, and the related interest were converted into common stock on September 01, 2021.

Convertible Promissory Note 6.2

On December 15, 2020, the Company and Steve Hall, entered into a convertible promissory note agreement for the principal amount of $250,000, accruing simple interest at a rate of 10% per annum, if repaid within 90 days, and 20% per annum if repaid thereafter. The convertible note was due on December 15, 2021. At the option of the noteholder, the note would convert at any time beginning six months after the date of issuance and ending on the date, which is one year from the date of issuance, at a conversion price of $0.25 per share.

The Company recorded a discount on the convertible note due to a beneficial conversion feature of $117,760, which is being amortized over the term of the note.

In consideration for the loan of $250,000, the Company also granted to Mr. Hall 100,000 stock options exercisable at $0.25 for a two-year term. The options vested upon issuance of the note. The fair value of the options was $46,380 and was recognized as debt discount as a part of beneficial conversion feature in the year ended June 30, 2021.

The outstanding principal amount, and the related interest were converted into common stock on September 01, 2021.

Adoption of ASU 2020-06 for Convertible Promissory Note 6.1, and Convertible Promissory Note 6.2

In connection with the adoption of ASU 2020-06, the Company reclassified the aggregate amount of $169,354, previously allocated to the conversion feature of the Convertible Promissory Note 6.1, and Convertible Promissory Note 6.2 of $51,594, and $117,760 from additional paid-in capital to convertible notes on our balance sheet as of September 1, 2021, respectively. The reclassification was recorded to combine the two legacy units of account into a single instrument classified as a liability. The Company also recognized an aggregate cumulative effect adjustment of $120,287 to the Convertible Promissory Note 6.1, and Convertible Promissory Note 6.2 of $51,594, and $68,693 to accumulated deficit on our balance sheet as of September 1, 2021, respectively. The cumulative effect adjustment was primarily driven by the derecognition of interest expense related to the accretion of the Debt Discount as required under the legacy accounting guidance. Under ASU 2020-06, we would no longer incur non-cash interest expense related to the accretion of the debt discount associated with the embedded conversion option.

Conversion of Convertible Promissory Note 6.1 and Convertible Promissory Note 6.2

On September 1, 2021, the Company had converted the convertible promissory note 6.1 and convertible promissory note 6.2 in the aggregate total of $500,000 and the related accrued interest of $94,344 into 16,666,667 shares of common stock with conversion value of $0.035661 per share. The entire amount of $594,344 has been converted into Common Stock on July 28, 2022. On November 2, 2021, the Company issued 160,000 shares of common stock for cashless exercise of the 200,000 stock options issued to Mr. Hall.

Exercise of the stock options on Convertible Promissory Note 6.1 and Convertible Promissory Note 6.2

On November 2, 2021, the Company issued 160,000 shares of common stock for the cashless exercise of the 200,000 stock options, mentioned in convertible promissory note 6.1 and convertible promissory note 6.2.

Convertible Promissory Note 6.3

On October 1, 2021, the inventory financing payable of $500,000 with Steve Hall as mentioned on Note 5 – Inventory Financing Payable – related party, has been exchanged for a convertible promissory note with annual simple interest rate of 12% for the first 90 days and annual simple interest rate of 20% thereafter, with a due date on September 30, 2022. At the option of holder, this note is convertible, at any time, into shares of common stock at a conversion price of $0.02 per share.

The note’s maturity date was extended to September 30, 2023.

As of December 31, 2022, the accrued interest under the note was $115,342, and the principal balance was $500,000.

XML

Line of Credit related party

6 Months Ended

Dec. 31, 2022

Line of Credit related party

Line of Credit - related party

Note 7 – Line of Credit – related party

On October 1, 2021, Steve Hall agreed to provide a line of credit of up to $1,000,000 to the Company with simple interest at a rate of 12% for the first 90 days, and simple interest at a rate of 20% per annum thereafter. The principal and interest payable shall be added to the principal amount of the agreement and payable pursuant to the same terms. The line of credit shall expire on October 1, 2022 unless renewed and/or extended by lender and borrower. Subsequently, the line of credit has been renewed and extended with same terms and an expiration date of October 1, 2023.

During the six months ended December 31, 2022, and 2021, in multiple transactions dates, the Company has withdrawn a total of $200,000, and 105,000, and has accrued interest of $11,280, and $962, respectively.

As of December 31, 2022, and 2021, the outstanding principal totaled $465,000, and 105,000 with accrued interest of $52,184, and $962, respectively.

XML

Common stock payable

6 Months Ended

Dec. 31, 2022

Common stock payable

Common stock payable

Note 8 – Common stock payable

On May 23, 2022, the board of directors granted Richard Cutler, former director who had resigned in August 2022, 500,000 shares of restricted common stock valued at $20,000, with an exercise price of $0.04 per share. The shares were granted as consideration for services granted. All shares are restricted until an acquisition or reverse takeover of the Company.

As of December 31, 2022 and 2021, the Company reported common stock payable of $20,000 and $0, which represents 500,000, and 0 shares of common stock to be issued, respectively.

XML

Common stock payable related party

6 Months Ended

Dec. 31, 2022

Common stock payable related party

Common stock payable related party

Note 9 – Common stock payable – related party

On May 23, 2022, the board of directors granted Chris Mulgrew, Chief Financial Officer, 250,000 shares of restricted common stock, valued at $10,000 with an exercise price of $0.04 per share. The shares were granted as consideration for services granted. All shares are restricted until an acquisition or reverse takeover of the Company.

As of December 31, 2022 and 2021, the Company reported common stock payable-related party of $10,000 and $20,000, which represents 250,000, and 1,108,000 shares of common stock to be issued, respectively.

XML

Stockholders Equity

6 Months Ended

Dec. 31, 2022

Stockholders Equity

Stockholders' Equity

Note 10 - Stockholders’ Equity

Common Stock

During the six months ended December 31, 2022, the Company had the following common stock transactions:

· 16,666,667 shares issued valued at $594,344 for settlement of two convertible notes to Steve Hall in aggregate amount of $500,000 and accrued interest of $94,344.  

Stock Purchase Warrants

Transactions in stock purchase warrants for the six months ended December 31, 2022 are as follows:

	Number of			Weighted Average
	Warrants			Exercise Price
Balance at June 30, 2021		2,493,996		$	1.00
Granted		-			-
Exercised – shares issued		-			-
Expired		-			-
Balance at September 30, 2022		2,493,996		$	1.00
Expired		(100,000	)		0.20
Balance at December 31, 2022		2,393,996		$	1.03

The composition of the Company’s warrants outstanding at December 31, 2022 are as follows:

Exercise Price		Number of Warrants		Weighted Average Remaining Life (in years)
$	0.30		349,998		1.33
$	0.50		666,666		1.33
$	1.00		708,666		1.33
$	2.00		668,666		1.33
			2,393,996		1.33

At December 31, 2022, the intrinsic value of the 2,393,996 outstanding warrant was $0.

Stock Options

Transactions in stock options for the six months ended December 31, 2022 are as follows:

					Weighted average
	Number of		Weighted average		remaining life
	options		exercise price		(in years)
Outstanding, June 30, 2022		4,256,000		0.14		4.41
Granted		-		-		-
Cancelled		-		-		-
Exercised		-		-		-
Outstanding, December 31, 2022		4,256,000		0.14		3.90
Exercisable, December 31, 2022		4,256,000	$	0.14		3.90

During the six months ended December 31, 2022, $5,159 was expensed to un-related parties, and $0 remains unamortized.

At December 31, 2022, the intrinsic value of the 4,256,000 outstanding options was $0.

XML

Commitments and Contingencies

6 Months Ended

Dec. 31, 2022

Commitments and contingencies (Notes 11)

Commitments and Contingencies

Note 11 - Commitments and Contingencies 

On July 17, 2020, the Company entered into a Membership Agreement (See “Note 4 - Joint Venture Investment in HIE LLC ”). Under the terms and conditions of the Membership Agreement, in the event of a loss of capital of HIE, the Company shall contribute to repay 33.3% of the Origination Loan and Additional Contribution and of any losses of HIE.

In addition, the Company is obliged to repay 1/3 of the loan contributed by Eagle or 1/3 of the capital paid by Eagle according to the membership agreement. As of December 31, 2022, and 2021, the balances of loan payable to Eagle - JV partner totaled $442,251, and $707,654, respectively.

HIE had no operating activities for the six months ended December 31, 2022. 

XML

Subsequent Events

6 Months Ended

Dec. 31, 2022

Subsequent Events

Subsequent Events

Note 12 - Subsequent Events

Management has evaluated subsequent events through the date these financial statements were available to be issued. Based on our evaluation no material events have occurred that require disclosure.

XML

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Dec. 31, 2022

Summary of Significant Accounting Policies

Business Overview

Hawkeye Systems, Inc. (the “Company”), a Nevada corporation incorporated on May 15, 2018. We are a technology holding company, our previous focus was on pandemic management products and services. We are currently seeking other opportunities, while actively trying to liquidate mask inventory and wind-up existing deals. The Company looks to license and acquire technology that improves life and to work with partners to develop cutting edge, “smart” products for a variety of markets. From inception until the date of this filing our activities have primarily consisted of (i) the incorporation of our Company, (ii) the development of our business plan and the evaluation of strategic investment and business development strategies, (iii), recruiting and adding additional consultants and employees, and (iv) liquidating our stock of personal protective equipment (“PPE”) products through numerous sources.

Basis of presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited condensed consolidated financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended June 30, 2022, as filed with the SEC on December 14, 2022.

Use of estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, valuation of beneficial conversion feature on convertible notes and the valuation allowance on deferred tax assets.

Fair value measurements

When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis.

Revenue recognition

As of December 31, 2022, and 2021, the Company has no revenue.

Cost of sales

As of December 31, 2022, and 2021, the Company has no Cost of Sales.

Basic and diluted earnings per share

Basic earnings per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable with accrued interest. For the six months ended December 31, 2022 and 2021, potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share because they were anti-dilutive are as follows:

	December 31,		December 31,
	2022		2021
Warrants		2,393,996		2,493,996
Options		4,256,000		1,006,000
Convertible notes		56,792,686		32,250,000
Common stock payable		750,000		-
Total possible dilutive shares		64,192,682		35,749,996

Recent Accounting Pronouncements

Management has considered all recent accounting pronouncements issued and their potential effect on our financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s unaudited condensed consolidated financial statements.

In August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt-Debt with Conversion and Other Options” and ASC subtopic 815-40 “Hedging-Contracts in Entity’s Own Equity”. The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting; and, (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years.

We early adopted this standard effective July 1, 2021 using the modified retrospective approach transition method. Therefore, the condensed financial statements for the six months ended December 31, 2022 are presented under the new standard, while the comparative period presented is not adjusted and continues to be reported in accordance with the Company’s historical accounting policy.

XML

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Dec. 31, 2022

Summary of Significant Accounting Policies

Schedule Of Basic and Diluted Earnings Per Share

	December 31,		December 31,
	2022		2021
Warrants		2,393,996		2,493,996
Options		4,256,000		1,006,000
Convertible notes		56,792,686		32,250,000
Common stock payable		750,000		-
Total possible dilutive shares		64,192,682		35,749,996

XML

Restatement of Financial Statements for the Quarter End December 31, 2021 (Tables)

6 Months Ended

Dec. 31, 2022

Restatement of Financial Statements for the Quarter End December 31, 2021

Schedule of restatement of asset, liability and equity

	Originally Reported			Restatement Adjustment			As Restated
Balance Sheet at December 31, 2021:
ASSETS
Current assets:
Cash	$	14,488		$	-		$	14,488
Prepaid expenses		25,833			-			25,833
Total current assets		40,321			-			40,321
Investment in HIE		-			245,667			245,667
Total assets	$	40,321		$	245,667		$	285,988
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable and accrued liabilities	$	163,314		$	-		$	163,314
Convertible note payable, net of discount - related party		1,105,000			-			1,105,000
Common stock payable - related party		200,000			-			200,000
Total current liabilities		1,468,314			-			1,468,314
Long-term liabilities:
Loan payable due to Eagle - JV partner		-			707,654			707,654
PPP loan		16,983			-			16,983
Total liabilities		1,485,297			707,654			2,192,951
Stockholders’ deficit:
Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding		-			-			-
Common stock, $0.0001 par value, 400,000,000 shares authorized; 25,604,148 shares issued and outstanding, respectively		2,536			-			2,536
Additional paid-in capital		8,452,632			-			8,452,632
Accumulated deficit		(9,900,144	)		(461,987	)		(10,362,131	)
Total stockholders’ equity deficit		(1,444,976	)		(461,987	)		(1,906,963	)
Total liabilities and stockholders’ deficit	$	40,321		$	(461,987	)	$	285,988

XML

Stockholders Equity (Tables)

6 Months Ended

Dec. 31, 2022

Stockholders Equity

Transactions in stock purchase warrants

	Number of			Weighted Average
	Warrants			Exercise Price
Balance at June 30, 2021		2,493,996		$	1.00
Granted		-			-
Exercised – shares issued		-			-
Expired		-			-
Balance at September 30, 2022		2,493,996		$	1.00
Expired		(100,000	)		0.20
Balance at December 31, 2022		2,393,996		$	1.03

Schedule of warrants outstanding

Exercise Price		Number of Warrants		Weighted Average Remaining Life (in years)
$	0.30		349,998		1.33
$	0.50		666,666		1.33
$	1.00		708,666		1.33
$	2.00		668,666		1.33
			2,393,996		1.33

Schedule Of Transactions in stock options

					Weighted average
	Number of		Weighted average		remaining life
	options		exercise price		(in years)
Outstanding, June 30, 2022		4,256,000		0.14		4.41
Granted		-		-		-
Cancelled		-		-		-
Exercised		-		-		-
Outstanding, December 31, 2022		4,256,000		0.14		3.90
Exercisable, December 31, 2022		4,256,000	$	0.14		3.90

XML

Summary of Significant Accounting Policies (Details) - shares	6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Warrant [Member]
Total possible dilutive shares	2,393,996	2,493,996
Convertible Note [Member]
Total possible dilutive shares	56,792,686	32,250,000
Options [Member]
Total possible dilutive shares	4,256,000	1,006,000
Common Stock Payable [Member]
Total possible dilutive shares	750,000
Total Possible Dilutive Shares [Member]
Total possible dilutive shares	64,192,682	35,749,996

XML

Going Concern (Details Narrative) - USD ($)	6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Jun. 30, 2022
Going Concern
Net loss	$ 481,388	$ 768,757
Accumulated deficit	$ (11,363,564)	$ (10,362,131)	$ (10,882,176)

XML

Restatement of Financial Statements for the Quarter End December 31, 2021 (Details) - USD ($)	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021
Prepaid expenses	$ 9,480		$ 1,333	$ 25,833
Total current assets	9,512		1,658	40,321
Investment in HIE				245,667		$ 245,667
Total assets	9,512		1,658	285,988
Accounts payable and accrued liabilities	557,675		273,592	163,314
Convertible note payable, net of discount - related party				1,105,000
Cash				14,488
Common stock payable - related party				200,000
Total current liabilities	1,525,260		1,662,936	1,468,314
Long-term liabilities:
Loan payable to Eagle - JV partner				707,654		707,654
PPP loan				16,983
Total Liabilities	1,994,926		2,105,187	2,192,951
Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding	0		0	0
Common stock, $0.0001 par value, 400,000,000 shares authorized; 25,604,148 shares issued and outstanding, respectively	4,227		2,560	2,536
Additional paid-in capital	9,373,923		8,776,087	8,452,632
Accumulated deficit	(11,363,564)		(10,882,176)	(10,362,131)
Total stockholders' equity deficit	(1,985,414)	$ (1,719,122)	(2,103,529)	(1,906,963)	$ (1,962,221)	$ (1,754,860)
Total liabilities and stockholders' deficit	$ 9,512		$ 1,658	285,988
Originally Reported [Member]
Prepaid expenses				25,833
Total current assets				40,321
Investment in HIE				0
Total assets				40,321
Accounts payable and accrued liabilities				163,314
Convertible note payable, net of discount - related party				1,105,000
Cash				14,488
Common stock payable - related party				200,000
Total current liabilities				1,468,314
Long-term liabilities:
Loan payable to Eagle - JV partner				0
PPP loan				16,983
Total Liabilities				1,485,297
Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding				0
Common stock, $0.0001 par value, 400,000,000 shares authorized; 25,604,148 shares issued and outstanding, respectively				2,536
Additional paid-in capital				8,452,632
Accumulated deficit				(9,900,144)
Total stockholders' equity deficit				(1,444,976)
Total liabilities and stockholders' deficit				40,321
Restatement Adjustment [Member]
Prepaid expenses				0
Total current assets				0
Investment in HIE				245,667
Total assets				245,667
Accounts payable and accrued liabilities				0
Convertible note payable, net of discount - related party				0
Cash				0
Common stock payable - related party				0
Total current liabilities				0
Long-term liabilities:
Loan payable to Eagle - JV partner				707,654
PPP loan				0
Total Liabilities				707,654
Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding				0
Common stock, $0.0001 par value, 400,000,000 shares authorized; 25,604,148 shares issued and outstanding, respectively				0
Additional paid-in capital				0
Accumulated deficit				(461,987)
Total stockholders' equity deficit				(461,987)
Total liabilities and stockholders' deficit				$ 461,987

XML

Restatement of Financial Statements for the Quarter End December 31, 2021 (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Jun. 30, 2021
Description of restatement effect on financial statements				HIE until October, 2022. For the fiscal year ended June 30, 2021, HIE had a loan balance of $2,122,963 secured by Eagle, of which the Company has recognized 1/3 amounting to $707,654 as a guarantee of loan payable to Eagle - JV partner
Other expenses				$ 461,987
Investment in HIE		$ 245,667		245,667	$ 245,667
Loan due to Eagle		707,654		707,654	$ 707,654
Operating loss	$ 219,327	$ 445,913	$ 393,808	704,869
Lender [Member]
Operating loss				$ 1,385,962

XML

Joint Venture Investment in HIE LLC (Details Narrative) - USD ($)	6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Jun. 30, 2021
Investment		$ 245,667	$ 245,667
Joint Venture Investment LLC [Member]
Investment	$ 0	$ 245,667
Percentage of interest of any net profits in shares	33.30%
Percentage of additional contribution and if any losses	33.30%

XML

Inventory Financing Payable Related Party (Details Narrative) - USD ($)	6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Inventory Financing Payable Related Party (Details Narrative)
Repayment to related party	$ 500,000
Convertible note	$ 0	$ 500,000
Related party transaction description	The purpose of the advance was to purchase inventory to satisfy customer orders. The advance would be repaid upon cash being received from the end customer. In addition to the principal amount of the advance, the related party will be entitled to 1/3 of the gross profit earned on the transaction. The terms of the agreement are non-interest bearing. The investor is 100% at risk as this is a non-recourse funding vehicle.

XML

Convertible Notes Payable Related Party (Details Narrative) - USD ($)			6 Months Ended
	Dec. 15, 2020	Apr. 06, 2020	Dec. 31, 2022	Dec. 31, 2021
Accrued interest			$ 52,184	$ 962
Lender [Member]
Beneficial conversion feature		$ 51,594
Convertible Promissory Note Two [Member]
Notes payable descriptions	On December 15, 2020, the Company and Steve Hall, entered into a convertible promissory note agreement for the principal amount of $250,000, accruing simple interest at a rate of 10% per annum, if repaid within 90 days, and 20% per annum if repaid thereafter. The convertible note was due on December 15, 2021
Conversion price			$ 0.25
Beneficial conversion feature			$ 117,760
Loan consideration			$ 250,000
Stock granted			100,000
Stock option exercisable			$ 0.25
Fair value of options			$ 46,380
Convertible Promissory Note Three [Member]
Notes payable descriptions			On October 1, 2021, the inventory financing payable of $500,000 with Steve Hall as mentioned on Note 5 – Inventory Financing Payable – related party, has been exchanged for a convertible promissory note with annual simple interest rate of 12% for the first 90 days and annual simple interest rate of 20% thereafter, with a due date on September 30, 2022
Conversion price			$ 0.02
Accrued interest			$ 115,342
Principal amount			$ 500,000
Convertible Promissory Note One [Member]
Conversion price			$ 0.25
Loan consideration			$ 250,000
Stock granted			100,000
Stock option exercisable			$ 0.25
Fair value of options			$ 13,297
Principal amount		$ 250,000
Interest rate		10.00%
Repayment period		90 years
Revised percentage rate		20.00%

XML

Line of Credit related party (Details Narrative) - USD ($)	6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Accrued interest	$ 52,184	$ 962
Outstanding principal	$ 465,000	105,000
On October 1, 2021 | Line of credit related party description | Steve Hall [Member]
Line of credit related party description	agreed to provide a line of credit of up to $1,000,000 to the Company with simple interest at a rate of 12% for the first 90 days, and simple interest at a rate of 20% per annum thereafter.
Expiry date of line of credit	October 1, 2023
Withdrawn amount	$ 200,000	105,000
Accrued interest	$ 11,280	$ 962

XML

Common stock payable (Details Narrative) - USD ($)	Dec. 31, 2022	May 23, 2022	Dec. 31, 2021
Common stock payable
Restricted Common stock value		$ 20,000
Conversion value		$ 0.04
Common stock payable	$ 20,000		$ 0
Restricted Common stock		500,000
Common stock issued	$ 500,000		$ 0

XML

Common stock payable related party (Details Narrative) - USD ($)	Dec. 31, 2022	May 23, 2022	Dec. 31, 2021
Common stock payable - related party	$ 10,000		$ 20,000
Common stock to be issued	250,000		1,108,000
Restricted Common stock		500,000
Restricted Common stock value		$ 20,000
Conversion value		$ 0.04
Chief Financial Officer[Member]
Restricted Common stock		250,000
Restricted Common stock value		$ 10,000
Conversion value		$ 0.04

XML

Stockholders Equity (Details) - Stock Purchase Warrants [Member] - USD ($)	3 Months Ended	6 Months Ended
	Sep. 30, 2022	Dec. 31, 2022
Warrant shares, Beginning	$ 2,493,996	$ 2,493,996
Warrant shares, Granted	0	0
Warrant shares,Exercised	0	0
Warrant shares, Expired	0	100,000
Warrant shares, Ending	$ 2,493,996	$ 2,393,996
Weighted average exercise price, Beginning	$ 1.00	$ 1.00
Weighted average exercise price, Granted	0	0
Weighted average exercise price, Exercised	0	0
Weighted average exercise price, Expired		0.20
Weighted average exercise price, Ending	$ 1.00	$ 1.03

XML

Stockholders Equity (Details 1)	6 Months Ended
	Dec. 31, 2022 $ / shares shares
Warrants outsanding 1 [Member]
Number of Warrants	349,998
Weighted Average Remaining Life (in years)	1 year 3 months 29 days
Exercise Price | $ / shares	$ 0.30
Warrants outsanding 2 [Member]
Number of Warrants	666,666
Weighted Average Remaining Life (in years)	1 year 3 months 29 days
Exercise Price | $ / shares	$ 0.50
Warrants outsanding 3 [Member]
Number of Warrants	708,666
Weighted Average Remaining Life (in years)	1 year 3 months 29 days
Exercise Price | $ / shares	$ 1.00
Warrants outsanding 4 [Member]
Number of Warrants	668,666
Weighted Average Remaining Life (in years)	1 year 3 months 29 days
Exercise Price | $ / shares	$ 2.00
Warrants outsanding [Member]
Number of Warrants	2,393,996
Weighted Average Remaining Life (in years)	1 year 3 months 29 days

XML

Stockholders Equity (Details 2) - Stock Options [Member]	6 Months Ended
	Dec. 31, 2022 $ / shares shares
Number of options, beginning balance	4,256,000
Number of options, Granted	0
Number of options, ending balance	4,256,000
Number of options, Exercisable	4,256,000
Weighted Average Exercise Price, beginning balance | $ / shares	$ 0.14
Weighted Average Exercise Price, ending balance | $ / shares	0.14
Weighted Average Exercise Price, Exercisable | $ / shares	$ 0.14
Weighted average remaining life, beginning	4 years 4 months 28 days
Weighted average remaining life, ending	3 years 10 months 24 days
Weighted average remaining life, exercisable	3 years 10 months 24 days

XML

Stockholders Equity (Details Narrative)	6 Months Ended
	Dec. 31, 2022 USD ($) shares
Common stock shares issued upon settlement of debt | shares	16,666,667
Common stock value issued upon settlement of debt	$ 594,344
Aggregate amount of debt settled	500,000
Accrued interest- debt settled	94,344
Stock Purchase Warrants [Member]
Number of warrants/rights outstanding, intrisic value	$ 0
Number of warrants/rights outstanding | shares	2,393,996
Stock Options [Member]
Number of warrants/rights outstanding, intrisic value	$ 0
Number of warrants/rights outstanding | shares	4,256,000
Share based compensation expense	$ 5,159
Share based compensation expense, unamortized	$ 0

XML

Commitments and Contingencies (Details Narrative) - Joint Venture Investment in HIE [Member] - USD ($)	3 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Lan payable	$ 442,251	$ 707,654
Percentage of additional contribution and if any losses	33.30%